InvestorsObserver
×
News Home

Caleres Inc. Down 0.11% To $27.42 After Earnings Beat

Tuesday, November 22, 2022 11:53 AM | InvestorsObserver Analysts

Mentioned in this article

Caleres Inc. Down 0.11% To $27.42 After Earnings Beat

Caleres Inc (CAL) beat out earnings estimates for Q3 2022 this morning.

Caleres Inc.'s earnings came in at an EPS of $1.15 per share, 3.00% higher than estimates for an EPS of $1.12 per share. The firm's earnings are down 28% since reporting $1.59 per share in the same period a year ago. Remember, earnings reported were on an adjusted basis, so they may not be comparable to prior reports and/or analyst estimates.

Consensus analyst estimates were at $784.6 million. The Consumer Cyclical company managed to surpass those expectations for its third quarter with revenue of $798.3 million, a positive revenue surprise of $13.7 million (2%). The firm managed 2% growth year-over-year due to Caleres Inc. reporting quarterly revenue of $784.2 million in its year-ago quarter. Caleres Inc. achieved a lower earnings growth rate than revenue, signaling that the business has not been able to improve its profit margin.

The stock is down 0.11% to $27.42 after the report.

The firm's higher revenue growth to earnings signals that the firm has not been able to reduce costs and has seen its profit margin decrease.

The average recommendation from Wall Street analysts was a Buy which may get revised based on this new data.

InvestorsObserver gives the stock a Bullish Sentiment score at the moment based on recent trading.

Caleres Inc. has performed a little above average during the past few months. Before the report, Caleres Inc. received a Long-Term Technical Rank by InvestorsObserver of 66, putting it in the top half of stocks. The firm set a 52-week high on August 23, 2022 at $31.13 and set a 52-week low on March 8, 2022 at $17.82.

Caleres Inc is a footwear retailer in the United States. The company is engaged in the operation of retail shoe stores and e-commerce websites, as well as the design, sourcing, and marketing of footwear for women and men. It offers products under Naturalizer, Dr. Scholl's, LifeStride, Ryka, and Franco Sarto brands. It operates approx 1,221 retail shoe stores in the United States, Canada, Guam, and Italy, primarily under the Famous Footwear, LifeStride, Naturalizer, Blowfish Malibu, Fergie Footwear, and Allen Edmonds names.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App